Enterobacteriaceae

Enterobacteriaceae
Public domain · source
Name	Enterobacteriaceae
Domain	Bacteria
Phylum	Proteobacteria
Classis	Gammaproteobacteria
Order	Enterobacterales
Subdivision ranks	Genera

Enterobacteriaceae Enterobacteriaceae are a large family of Gram-negative, facultatively anaerobic bacilli historically grouped within the order Enterobacterales. Members have been isolated from humans, animals, plants, soil and water and have central roles in medicine, agriculture and biotechnology; notable genera include Escherichia, Salmonella, Klebsiella, Enterobacter and Proteus. Research on these bacteria intersects with institutions such as the World Health Organization, Centers for Disease Control and Prevention, Wellcome Trust, National Institutes of Health and initiatives like the Global Antimicrobial Resistance Surveillance System.

Taxonomy and Classification

The taxonomic history of the family reflects contributions from figures and organizations such as Carl Woese, Stanley Falkow, International Committee on Systematics of Prokaryotes, Bergey's Manual Trust, Society for General Microbiology and national culture collections like the American Type Culture Collection and the Deutsche Sammlung von Mikroorganismen und Zellkulturen. Molecular phylogenetics using 16S rRNA, multilocus sequence typing and whole-genome sequencing applied by groups at Broad Institute, Wellcome Sanger Institute, European Molecular Biology Laboratory and universities such as Harvard University, University of Oxford, Stanford University, Massachusetts Institute of Technology and University of Cambridge reshaped classification, splitting and reassigning genera and species. Taxa revisions have been published in journals like International Journal of Systematic and Evolutionary Microbiology, Nature Microbiology, The Lancet Infectious Diseases and databases maintained by NCBI, UniProt, Genome Taxonomy Database and European Nucleotide Archive.

Morphology and Physiology

Members are rod-shaped cells characterized by Gram-negative cell envelopes studied in laboratories affiliated with Max Planck Society, Cold Spring Harbor Laboratory and Johns Hopkins University Hospital. Physiological assays developed or standardized by groups at Food and Drug Administration, European Food Safety Authority, Agricultural Research Service and research centers such as Rothamsted Research examine traits including oxidase negativity, facultative anaerobiosis, fermentative metabolism of glucose, catalase activity and motility mediated by peritrichous flagella in genera like Proteus mirabilis and Escherichia coli. Biochemical profiling platforms from companies like bioMérieux, BD Diagnostics, Merck Group and methods described by researchers at Yale University, Columbia University, University of California, San Francisco and University of Pennsylvania distinguish lactose fermenters (e.g., Klebsiella pneumoniae, Escherichia coli) from non-fermenters (e.g., Salmonella enterica) using selective media developed historically in reference laboratories such as Institut Pasteur and Robert Koch Institute.

Ecology and Habitats

Enteric-associated genera inhabit gastrointestinal tracts of hosts studied by groups at Rockefeller University, Salk Institute, Pasteur Institute of Iran and veterinary centers like Cornell University College of Veterinary Medicine and Royal Veterinary College. Environmental reservoirs include freshwater systems monitored by United Nations Environment Programme, agricultural soils researched at University of Wageningen, University of São Paulo and University of Tokyo, and food processing environments inspected by agencies such as Food and Agriculture Organization and United States Department of Agriculture. Outbreak investigations led by teams from Public Health England, European Centre for Disease Prevention and Control, Robert Koch Institute and CDC Epidemic Intelligence Service have traced sources to E. coli O157:H7 contamination in beef supply chains linked to facilities regulated by Department of Agriculture and to Salmonella in poultry production overseen by National Chicken Council.

Clinical Significance and Pathogenicity

Clinically important species cause urinary tract infections, sepsis, gastroenteritis and nosocomial pneumonia; major clinical centers reporting case series include Mayo Clinic, Cleveland Clinic, Mount Sinai Hospital, Johns Hopkins Hospital and Massachusetts General Hospital. Pathogenesis research funded by entities such as Gates Foundation and reported in outlets like New England Journal of Medicine, The Lancet, Clinical Infectious Diseases and Journal of Clinical Microbiology implicates virulence factors—adhesins, invasins, siderophores, endotoxin (lipopolysaccharide), capsules and type III secretion systems—characterized in model organisms at European Molecular Biology Laboratory, EMBL-EBI, University of California, Berkeley and Princeton University. Public health responses by WHO, CDC, ECDC and national ministries documented outbreaks involving strains such as E. coli O157:H7, Salmonella Typhi, Klebsiella pneumoniae carbapenemase producers and Shigella species with global impact on morbidity in regions served by Doctors Without Borders, Red Cross, Bill & Melinda Gates Foundation initiatives and national healthcare systems in India, Nigeria, Brazil and China.

Antimicrobial Resistance and Treatment

Antimicrobial resistance in these bacteria has been a focus of research at Wellcome Trust Sanger Institute, CDC Antibiotic Resistance Laboratory Network, UK Health Security Agency and consortia including ReAct, Global Antibiotic Research and Development Partnership and pharmaceutical companies like Pfizer, GlaxoSmithKline, Roche and Novartis. Mechanisms such as extended-spectrum β-lactamases, carbapenemases (e.g., KPC, NDM, OXA-48), plasmid-mediated colistin resistance (mcr) and efflux pump upregulation have been characterized in studies from Johns Hopkins University, Imperial College London, Karolinska Institute, University of Melbourne and National University of Singapore. Treatment guidelines from bodies like Infectious Diseases Society of America, European Society of Clinical Microbiology and Infectious Diseases, World Health Organization and national health services recommend stewardship strategies, combination therapy and development pipelines supported by public–private partnerships including CARB-X and initiatives at US Department of Health and Human Services.

Laboratory Identification and Diagnostic Methods

Clinical and reference laboratories at institutions such as Mayo Clinic Laboratories, Quest Diagnostics, ARUP Laboratories and university hospitals use culture on selective agars (MacConkey, XLD), biochemical panels (API, VITEK), mass spectrometry (MALDI-TOF) and molecular assays (PCR, whole-genome sequencing) with workflows developed by companies and centers including bioMérieux, Bruker, Illumina, Oxford Nanopore Technologies and consortia at Wellcome Sanger Institute and CDC. Rapid diagnostics deployed during outbreaks have been implemented by teams from Public Health England, European Centre for Disease Prevention and Control, World Health Organization and research groups at Broad Institute and Los Alamos National Laboratory to detect resistance genes (bla, mcr, etc.) and virulence determinants. Quality assurance, biosafety and data reporting frameworks are coordinated through organizations such as Clinical and Laboratory Standards Institute, International Organization for Standardization, Centers for Disease Control and Prevention and national accreditation bodies including United Kingdom Accreditation Service.

Category:Bacteria